Integrative Molecular Phenotyping
INTEGRATIVE MOLECULAR
PHENOTYPING
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY

Years

Publications

MP Hezel, M Liu, TA Schiffer, FJ Larsen, A Checa, CE Wheelock, M Carlström, JO Lundberg, E Weitzberg, 2015. Effects of long-term dietary nitrate supplementation in mice. Redox Biology. 29(5):234-242.
MA Kamleh, SG Snowden, G Blackburn, DG Watson, N Xu, M Ståhle, and CE Wheelock, 2015. LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment. Journal of Proteome Research, 14:557-566.
JD Brannan, J Bood, A Alkhabaz, D Balgoma, J Otis, I Delin, B Dahlén, CE Wheelock, P Nair, SE Dahlén, PM O'Byrne, 2015. The effect of omega-3 fatty acids on bronchial hyperresponsiveness, sputum eosinophilia and mast cell mediators in asthma. Chest, 147(2):397-405.
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis. Checa A, Khademi M, Sar DG, Haeggström JZ, Lundberg JO, Piehl F, Olsson T, Wheelock CE. Mult Scler. 2014 Dec 5. pii: 1352458514561908.
S Snowden, D Grapov, M Settergren, FL D’Alexandri, T Pedersen, JZ Haeggström, JW Newman, O Fiehn, T Hyötyläinen, M Orešič, J Pernow, CE Wheelock, 2014. High dose simvastatin exhibits enhanced lipid lowering effects relative to simvastatin/ezetimibe combination therapy. Circulation: Cardiovascular Genetics, 7(6):955-64.
D Diez, A Agusti, and CE Wheelock, 2014. Network analysis in the investigation of chronic respiratory diseases: from basics to application. American Journal of Respiratory and Critical Care Medicine, 190(9):981-8.
LC van den Berk, BJ Jansen, S Snowden, KG Siebers-Vermeulen, C Gilissen, G Kögler, CG Figdor, CE Wheelock, R Torensma, 2014. Cord blood mesenchymal stem cells suppress DC-T cell proliferation via prostaglandinB2. Stem Cells and Development, 23(14):1582-93.
K Daham, A James, D Balgoma, M Kupczyk, B Billing, A Lindeberg, E Henriksson, GA Fitzgerald, CE Wheelock, SE Dahlén, B Dahlén, 2014. Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma. Journal of Allergy and Clinical Immunology, 134(2):306-13.
FJ Larsen, TA Schiffer, B Ekblom, MP Mattsson, A Checa, CE Wheelock, T Nyström, JO Lundberg, E Weitzberg. Dietary nitrate reduces resting metabolic rate: a randomized, crossover study in humans, 2014. American Journal of Clinical Nutrition, 99(4):843-50.
N Larsson, SL Lundström, R Pinto, G Rankin, M Karimpour, A Blomberg, T Sandström, J Pourazar, J Trygg, AF Behndig, CE Wheelock*, and ML Nording, 2014. Lipid mediator profiles differ between lung compartments in asthmatic and healthy humans. European Respiratory Journal, 43(2):453-63.
Wheelock CE, Goss VM, Balgoma D, Nicholas B, Brandsma J, Skipp PJ, Snowden S, Burg D, D'Amico A, Horvath I, Chaiboonchoe A, Ahmed H, Ballereau S, Rossios C, Chung KF, Montuschi P, Fowler SJ, Adcock IM, Postle AD, Dahlén SE, Rowe A, Sterk PJ, Auffray C, Djukanovic R; the U-BIOPRED Study Group, 2013. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. European Respiratory Journal 42(3):802-25.
Wheelock ÅM, Wheelock CE, 2013. Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine. Molecular Biosystems 9(11):2589-96.
D Balgoma, A Checa, DG Sar, S Snowden, and CE Wheelock, 2013. Metabolic profiling of lipid mediators in disease. Molecular Nutrition and Food Research, 57(8):1359-77.
SL Lundström, J Yang, JD Brannan, JZ Haeggström, BD Hammock, P Nair, P O’Byrne, SE Dahlén, and CE Wheelock, 2013. Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acids. Molecular Nutrition and Food Research, 57(8):1378-89.
SL Lundström, R Saluja, M Adner, JZ Haeggström, G Nilsson, and CE Wheelock, 2013. Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations. Journal Lipid Research. 54(1):116-26.
A Nasi, T Fekete, A Krishnamurthy, S Snowden, E Rajnavölgyi, AI Catrina, CE Wheelock, N Vivar, B Rethi. Dendritic cell reprogramming by endogenously produced lactic acid, 2013. Journal of Immunology. 191(6):3090-9.
D Balgoma, J Larsson, J Rokach, JA Lawson, K Daham, B Dahlén, SE Dahlén, CE Wheelock. Quantification of Lipid Mediator Metabolites in Human Urine from Asthma Patients by Electrospray Ionization Mass Spectrometry: Controlling Matrix Effects. Analytical Chemistry, 85(16):7866-74.
A Nasi, T Fekete, A Krishnamurthy, S Snowden, E Rajnavölgyi, AI Catrina, CE Wheelock, N Vivar, B Rethi. Dendritic cell reprogramming by endogenously produced lactic acid, 2013. Journal of Immunology. 191(6):3090-9.
GM Kirwan, E Johansson, R Kleemann, ER Verheij, ÅM Wheelock, S Goto, J Trygg, and CE Wheelock, 2012. Building multivariate systems biology models. Analytical Chemistry 84(16):7064-71.
S Snowden, SE Dahlén, and CE Wheelock, 2012. Application of metabolomics approaches to the study of respiratory diseases. Bioanalysis special issue on “Metabolomics”, Guest Editor Andy Nicholls, 4(18):2265-90.

Pages